SARS-CoV-2

Immunocompromised individuals need regular boosters for Covid-19 protection

by

The Crucial Role of Vaccine Boosters for Immunosuppressed Individuals The University of Cambridge’s recent study published in *Science Advances* underscores the importance of regular vaccine boosters for immunocompromised individuals to protect them from prolonged and severe infections. Despite initial vaccination efforts, these individuals often require multiple doses, potentially up to four or more, to achieve … Read more

Are we prepared for the next outbreak?

by

The Intersection of Climate Change and Emerging Viral Threats Climate change is no longer just a distant concern—it’s affecting today’s viral landscape in profound ways. Studies indicate a worrying trend: as the planet warms, vectors like mosquitoes are expanding their habitats, bringing diseases such as the dengue and Zika viruses to areas previously unaffected. Did … Read more

New tool detects highly transmissible SARS-CoV-2 variants early

by

The Next Frontier: Predicting Viral Mutations Before They Spread Researchers have unveiled a groundbreaking tool to detect SARS-CoV-2 variants with high transmission potential, enabling earlier interventions. By examining millions of viral genome sequences globally, the tool identifies mutations that could significantly bolster the virus’s spread before they become widespread. This approach is poised to revolutionize … Read more

Fluoxetine not effective for COVID-19 patients

by

Understanding Antiviral Drug Efficacy: Key Insights from Recent Studies In the ongoing battle against COVID-19, several antiviral drugs have been studied to determine their effectiveness. A recent study, published in eClinicalMedicine, evaluated the antiviral efficacy of fluoxetine, a commonly used antidepressant. What Drives Antiviral Testing in SSRIs? Selective serotonin reuptake inhibitors (SSRIs) like fluoxetine have … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]